2024 FDA approvals
Nature Reviews Drug Discovery – The FDA approved 50 new therapeutics in 2024, with green lights for a novel schizophrenia drug, a first NASH medicine and much more.
Nature Reviews Drug Discovery – The FDA approved 50 new therapeutics in 2024, with green lights for a novel schizophrenia drug, a first NASH medicine and much more.
Nature Communications – Limitations in performance and stability of organic electrochemical transistors hinder their application in biosignal amplification. Here, the authors show that high-spin,…
Nature Communications – The authors demonstrate an information-filterable artificial retina system for signal perception and processing with attention, using metal-organic framework-based…
Nature Communications – The limited operational stability of multi-resonance thermally activated delayed fluorescence emitters often constrains their practical application. Here, the authors report…
Nature Communications – Achieving high-performance conjugated polymers with intrinsic flexibility and printable capacity is a great challenge. Here, the authors report asymmetric substituted…
Amy Moore: PD-1/VEGF combos are a strategy to watch in lung cancer / Amy Moore, cancer, Immune Checkpoint Inhibitors, Keiju Aokage, Lung cancer, Masahiro
The IACH is thrilled to invite you to join us on an enlightening journey through the evolution of hematology. In this exclusive webinar series, we…
Learn about submission, peer-review, production, billing, licensing, indexing, and post-publication promotion at Oncotarget
Nature Reviews Nephrology – Innate immune memory represents a barrier to successful kidney transplantation. The discovery that uraemic toxins in people with kidney failure induce…
Nature Reviews Clinical Oncology – Despite lower levels of most targetable alterations, a strong association with a history of smoking and generally higher levels of…
Polio expert Walter Orenstein speaks about the important legacy of the polio vaccine following efforts to undermine it